These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 7844376)
1. Pharmacologic inhibitors of tumor necrosis factor production exert differential effects in lethal endotoxemia and in infection with live microorganisms in mice. Netea MG; Blok WL; Kullberg BJ; Bemelmans M; Vogels MT; Buurman WA; van der Meer JW J Infect Dis; 1995 Feb; 171(2):393-9. PubMed ID: 7844376 [TBL] [Abstract][Full Text] [Related]
2. The yeast to hyphal transition following hematogenous candidiasis induces shock and organ injury independent of circulating tumor necrosis factor-alpha. Matuschak GM; Lechner AJ Crit Care Med; 1997 Jan; 25(1):111-20. PubMed ID: 8989186 [TBL] [Abstract][Full Text] [Related]
3. Effect of pentoxifylline on the course of systemic Candida albicans infection in mice. Louie A; Baltch AL; Franke MA; Ritz WJ; Smith RP; Singh JK; Gordon MA J Antimicrob Chemother; 1996 May; 37(5):943-54. PubMed ID: 8737144 [TBL] [Abstract][Full Text] [Related]
4. Effects of pentoxifylline on tumor necrosis factor production and survival during lethal E. coli sepsis vs. disseminated candidiasis with fungal septic shock. Lechner AJ; Rouben LR; Potthoff LH; Tredway TL; Matuschak GM Circ Shock; 1993 Apr; 39(4):306-15. PubMed ID: 8485822 [TBL] [Abstract][Full Text] [Related]
5. Differential gene expression for IL-1 receptor antagonist, IL-1, and TNF receptors and IL-1 and TNF synthesis may explain IL-1-induced resistance to infection. Vogels MT; Mensink EJ; Ye K; Boerman OC; Verschueren CM; Dinarello CA; van der Meer JW J Immunol; 1994 Dec; 153(12):5772-80. PubMed ID: 7989774 [TBL] [Abstract][Full Text] [Related]
6. [Therapeutic strategies against mediators of septic shock]. Zabel P; Schade FU Immun Infekt; 1993 Apr; 21(2):45-50. PubMed ID: 8340137 [TBL] [Abstract][Full Text] [Related]
7. Enhanced release of interleukin-10 and soluble tumor necrosis factor receptors as novel principles of methylxanthine action in murine models of endotoxic shock. Jilg S; Barsig J; Leist M; Küsters S; Volk HD; Wendel A J Pharmacol Exp Ther; 1996 Jul; 278(1):421-31. PubMed ID: 8764378 [TBL] [Abstract][Full Text] [Related]
8. The effects of dexamethasone and chlorpromazine on tumour necrosis factor-alpha, interleukin-1 beta, interleukin-1 receptor antagonist and interleukin-10 in human volunteers. Bleeker MW; Netea MG; Kullberg BJ; Van der Ven-Jongekrijg J; Van der Meer JW Immunology; 1997 Aug; 91(4):548-52. PubMed ID: 9378493 [TBL] [Abstract][Full Text] [Related]
9. Defective innate antibacterial host responses during murine Klebsiella pneumoniae bacteremia: tumor necrosis factor (TNF) receptor 1 deficiency versus therapy with anti-TNF-alpha. Moore TA; Lau HY; Cogen AL; Standiford TJ Clin Infect Dis; 2005 Aug; 41 Suppl 3():S213-7. PubMed ID: 15983903 [TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect on LPS-induced tumor necrosis factor in calves treated with chlorpromazine or pentoxifylline. Ohtsuka H; Higuchi T; Matsuzawa H; Sato H; Takahashi K; Takahashi J; Yoshino TO J Vet Med Sci; 1997 Nov; 59(11):1075-7. PubMed ID: 9409530 [TBL] [Abstract][Full Text] [Related]
12. Granulocyte-colony stimulating factor (G-CSF)-induced mechanical hyperalgesia in mice: Role for peripheral TNFα, IL-1β and IL-10. Carvalho TT; Borghi SM; Pinho-Ribeiro FA; Mizokami SS; Cunha TM; Ferreira SH; Cunha FQ; Casagrande R; Verri WA Eur J Pharmacol; 2015 Feb; 749():62-72. PubMed ID: 25584775 [TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of the phosphodiesterase inhibitors BRL 61063, pentoxifylline, and rolipram in a murine model of endotoxin shock. Badger AM; Olivera DL; Esser KM Circ Shock; 1994 Dec; 44(4):188-95. PubMed ID: 7628060 [TBL] [Abstract][Full Text] [Related]
14. Protective effect of pentoxifylline plus thalidomide against septic shock in mice. Arrieta O; Ortiz-Reyes A; Rembao D; Calvillo M; Rivera E; Sotelo J Int J Exp Pathol; 1999 Feb; 80(1):11-6. PubMed ID: 10365082 [TBL] [Abstract][Full Text] [Related]
15. Pentoxifylline improves survival and reduces tumor necrosis factor, interleukin-6, and endothelin-1 in fulminant intra-abdominal sepsis in rats. Lundblad R; Ekstrøm P; Giercksky KE Shock; 1995 Mar; 3(3):210-5. PubMed ID: 7773801 [TBL] [Abstract][Full Text] [Related]
16. An open study of pentoxyfylline and thalidomide as adjuvant therapy in the treatment of rheumatoid arthritis. Huizinga TW; Dijkmans BA; van der Velde EA; van de Pouw Kraan TC; Verweij CL; Breedveld FC Ann Rheum Dis; 1996 Nov; 55(11):833-6. PubMed ID: 8976641 [TBL] [Abstract][Full Text] [Related]
17. Pentoxifylline increases survival in murine endotoxin shock and decreases formation of tumor necrosis factor. Schade UF Circ Shock; 1990 Jun; 31(2):171-81. PubMed ID: 2344657 [TBL] [Abstract][Full Text] [Related]
18. Pentoxifylline protects against endotoxin-induced acute renal failure in mice. Wang W; Zolty E; Falk S; Basava V; Reznikov L; Schrier R Am J Physiol Renal Physiol; 2006 Nov; 291(5):F1090-5. PubMed ID: 16985210 [TBL] [Abstract][Full Text] [Related]
19. Divergent effects of tumor necrosis factor-alpha and lymphotoxin-alpha on lethal endotoxemia and infection with live Salmonella typhimurium in mice. Dharmana E; Keuter M; Netea MG; Verschueren IC; Kullberg BJ Eur Cytokine Netw; 2002; 13(1):104-9. PubMed ID: 11956028 [TBL] [Abstract][Full Text] [Related]